Anra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 3.00 M
- Company Age 31 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.77 M
- Revenue Growth 163.23%
- Profit Growth 226.53%
- Ebitda 147.77%
- Net Worth 166.02%
- Total Assets 64.21%
About Anra Pharmaceuticals
Anra Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 July 1993 and has a history of 31 years and six months. Its registered office is in Madurai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.00 M.
The company has closed loans amounting to ₹4.77 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Raja Ganesan and Mamundi Raja serve as directors at the Company.
Company Details
- Location
Madurai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN1993PTC025515
- Company No.
025515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Anra Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raja Ganesan  | Managing Director | 29-Jul-1993 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mamundi Raja | Director | 31-Dec-2017 | Current |
Financial Performance of Anra Pharmaceuticals.
Anra Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 163.23% increase. The company also saw a substantial improvement in profitability, with a 226.53% increase in profit. The company's net worth Soared by an impressive increase of 166.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anra Pharmaceuticals?
In 2018, Anra Pharmaceuticals had a promoter holding of 56.67% and a public holding of 43.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.77 M
Charges Breakdown by Lending Institutions
- The Tamilnadu Industrial Investments Corporation Ltd. : 0.33 Cr
- State Bank Of India : 0.08 Cr
- The Tamilnadu Industirial Investment Cor. Ltd. : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 1999 | The Tamilnadu Industirial Investment Cor. Ltd. | ₹0.69 M | Satisfied |
| 26 Mar 1997 | The Tamilnadu Industrial Investments Corporation Ltd. | ₹0.17 M | Satisfied |
| 05 Jun 1996 | State Bank Of India | ₹0.80 M | Satisfied |
| 23 Jun 1995 | The Tamilnadu Industrial Investments Corporation Ltd. | ₹3.11 M | Satisfied |
How Many Employees Work at Anra Pharmaceuticals?
Anra Pharmaceuticals has a workforce of 5 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
